Literature DB >> 23012712

I148M PNPLA3 variant and progressive liver disease: a new paradigm in hepatology.

Luca Valenti, Anna Alisi, Valerio Nobili.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23012712

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  9 in total

Review 1.  Calcium-independent phospholipases A2 and their roles in biological processes and diseases.

Authors:  Sasanka Ramanadham; Tomader Ali; Jason W Ashley; Robert N Bone; William D Hancock; Xiaoyong Lei
Journal:  J Lipid Res       Date:  2015-05-28       Impact factor: 5.922

2.  Nonalcoholic fatty liver disease and the heart in children and adolescents.

Authors:  Lucia Pacifico; Claudio Chiesa; Caterina Anania; Antonio De Merulis; John Frederick Osborn; Sara Romaggioli; Eugenio Gaudio
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 3.  PNPLA3 I148M polymorphism and progressive liver disease.

Authors:  Paola Dongiovanni; Benedetta Donati; Roberta Fares; Rosa Lombardi; Rosellina Margherita Mancina; Stefano Romeo; Luca Valenti
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

Review 4.  Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.

Authors:  Silvia Fargion; Marianna Porzio; Anna Ludovica Fracanzani
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 5.  Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis.

Authors:  Paola Dongiovanni; Stefano Romeo; Luca Valenti
Journal:  Biomed Res Int       Date:  2015-07-27       Impact factor: 3.411

6.  PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.

Authors:  Luca Valenti; Benedetta Maria Motta; Giorgio Soardo; Massimo Iavarone; Benedetta Donati; Angelo Sangiovanni; Alessia Carnelutti; Paola Dongiovanni; Raffaela Rametta; Cristina Bertelli; Floriana Facchetti; Massimo Colombo; Silvia Fargion; Anna Ludovica Fracanzani
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

7.  Identification of combined genetic determinants of liver stiffness within the SREBP1c-PNPLA3 pathway.

Authors:  Marcin Krawczyk; Frank Grünhage; Frank Lammert
Journal:  Int J Mol Sci       Date:  2013-10-22       Impact factor: 5.923

8.  Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment.

Authors:  Paola Dongiovanni; Quentin M Anstee; Luca Valenti
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 9.  Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease.

Authors:  Luca Valenti; Patrizia Riso; Alessandra Mazzocchi; Marisa Porrini; Silvia Fargion; Carlo Agostoni
Journal:  Oxid Med Cell Longev       Date:  2013-10-24       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.